Structured care of patients with atrial fibrillation improves guideline adherence
- PMID: 29250257
- PMCID: PMC5673316
- DOI: 10.4022/jafib.1498
Structured care of patients with atrial fibrillation improves guideline adherence
Abstract
Aims: There are many reports of lack of guideline adherence in the treatment of patients with atrial fibrillation (AF), and AF affects health-related quality of life (HRQoL) negatively. The aim of this study was to investigate whether structured care compared to standard care of a general AF population could improve guideline adherence and HRQoL, and reduce symptoms,anxiety and depression.
Methods: In total, 176 patients were recruited to the intervention and 146 patients to the control group.The intervention consisted of a structured follow-up program, while patients serving as controls received standard care. The primary outcome was guideline adherence evaluated through: appropriate use of oral anticoagulants (OAC) and antiarrhythmics, whether echocardiogram and thyroid lab tests were performed, and patient-reported outcome measures (PROMs), assessed with the questionnaires SF-36, EQ-5D, HADS and ASTA at baseline and after one year.
Results: Guideline adherence was significantly better in the intervention group, 91% vs. 63% (p < 0.01), mainly due to appropriate OAC treatment 94% vs. 74% (p < 0.01). Symptoms assessed with ASTA were less frequent and the negative impact of AF was reduced in the intervention group after one year/ at follow-up. Five scales in SF-36, and the visual analogue scale for current health status in EQ-5D (EQ-VAS), improved significantly in both groups.
Conclusion: Structured care of patients with AF significantly improved guideline adherence and patients reported fewer symptoms and a reduced negative impact on disease-specific HRQoL compared to standard care at one year follow-up.
Keywords: Anticoagulants; Anxiety; Atrial fibrillation; Guideline Adherence; Health-related Quality of life; Symptoms.
Figures
References
-
- Friberg L, Bergfeldt L. Atrial fibrillation prevalence revisited. J. Intern. Med. 2013 Nov;274 (5):461–8. - PubMed
-
- Camm A John, Kirchhof Paulus, Lip Gregory Y H, Schotten Ulrich, Savelieva Irene, Ernst Sabine, Van Gelder Isabelle C, Al-Attar Nawwar, Hindricks Gerhard, Prendergast Bernard, Heidbuchel Hein, Alfieri Ottavio, Angelini Annalisa, Atar Dan, Colonna Paolo, De Caterina Raffaele, De Sutter Johan, Goette Andreas, Gorenek Bulent, Heldal Magnus, Hohloser Stefan H, Kolh Philippe, Le Heuzey Jean-Yves, Ponikowski Piotr, Rutten Frans H. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010 Oct;12 (10):1360–420. - PubMed
-
- Deplanque Dominique, Leys Didier, Parnetti Lucilla, Schmidt Reinhold, Ferro Jose, De Reuck Jacques, Mas Jean-Louis, Gallai Virgilio. Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study. Br J Clin Pharmacol. 2004 Jun;57 (6):798–806. - PMC - PubMed
-
- Nieuwlaat Robby, Capucci Alessandro, Lip Gregory Y H, Olsson S Bertil, Prins Martin H, Nieman Fred H, López-Sendón José, Vardas Panos E, Aliot Etienne, Santini Massimo, Crijns Harry J G M. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur. Heart J. 2006 Dec;27 (24):3018–26. - PubMed
-
- Frykman V, Beerman B, Rydén L, Rosenqvist M. Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur. Heart J. 2001 Oct;22 (20):1954–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous